STI571 and gastro intestinal stromal tumors

被引：0
|
作者：
Ray-Coquard, I
Le Cesne, A
Blay, JY
机构：
[1] Ctr Leon Berard, F-69008 Lyon, France
[2] Inst Gustave Roussy, Villejuif, France
来源：
BULLETIN DU CANCER | 2001年 / 88卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：661 / 662
页数：2
相关论文
共 50 条
  • [41] Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia
    Gorre, ME
    Sawyers, CL
    CURRENT OPINION IN HEMATOLOGY, 2002, 9 (04) : 303 - 307
  • [42] Trial of IFN or STI571 before proceeding to allografting for CML?
    R Hehlmann
    Leukemia, 2000, 14 : 1560 - 1562
  • [43] A treatment using STI571 for jejunal gastrointestinal stromal tumor (GIST) accompanied with liver metastasis and peritoneal dissemination
    Okamoto, K
    Muguruma, N
    Aoki, R
    Sato, Y
    Nakamoto, J
    Imoto, Y
    Okamura, S
    Ito, S
    Okitsu, H
    Sano, T
    INTERNAL MEDICINE, 2004, 43 (12) : 1151 - 1156
  • [44] Inhibition of multiple myeloma proliferation by imatinib mesylate (STI571).
    Pandiella, A
    Carvajal, X
    Tabera, S
    Mateo, G
    San Miguel, JF
    BLOOD, 2002, 100 (11) : 601A - 601A
  • [45] STI571(Gleevec) therapy in idiopathic and postpolycythemic myelofibrosis.
    Hasselbalch, HC
    Bjerrum, OW
    Jensen, BA
    Hansen, PB
    Birgens, H
    BLOOD, 2002, 100 (11) : 344B - 344B
  • [46] STI571的耐药机制及其克服对策
    俞文娟
    国外医学输血及血液学分册., 2003, (03) : 260 - 264
  • [47] Low concentrations of STI571 in the cerebrospinal fluid:: a case report
    Petzer, AL
    Gunsilius, E
    Hayes, M
    Stockhammer, G
    Duba, HC
    Schneller, F
    Grünewald, K
    Poewe, W
    Gastl, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) : 623 - 625
  • [48] Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
    A Hochhaus
    S Kreil
    AS Corbin
    P La Rosée
    MC Müller
    T Lahaye
    B Hanfstein
    C Schoch
    NCP Cross
    U Berger
    H Gschaidmeier
    BJ Druker
    R Hehlmann
    Leukemia, 2002, 16 : 2190 - 2196
  • [49] STI571: Targeting BCR-ABL as therapy for CML
    Mauro, MJ
    Druker, BJ
    ONCOLOGIST, 2001, 6 (03): : 233 - 238
  • [50] In vitro and in vivo STI571 efficacy in neuroectodermal tumor cells
    Kronnie, GT
    Ricotti, E
    Rinaldi, A
    Creseenzio, N
    Spinelli, M
    Timeus, F
    Rosolen, A
    Basso, G
    BLOOD, 2002, 100 (11) : 220B - 220B
12345